Discussion Forums > Working Towards a Cure

Bluebird Bio Releases Data on Current Gene Therapy Trials

<< < (19/39) > >>

Andy Battaglia:
The latest update from Bluebird has been released.
Very good news that gene therapy is working for the sickle cell patient, as well.

http://investor.bluebirdbio.com/phoenix.zhtml?c=251820&p=irol-newsArticle&ID=2058989

--- Quote ---bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 Study at EHA
Patient with Severe Sickle Cell Disease Producing 45% Anti-sickling Hemoglobin at Six Months and Has Been Free of Transfusions for More Than Three Months
Patients with Beta-thalassemia Major Remain Transfusion-Independent at 16 and 14 Months, Respectively
First Patient with Severe Sickle Cell Disease Infused in HGB-206 Study
--- End quote ---

Sharmin:
Such great news Andy!  Thank you for sharing!!

catchR:
This is great news! Bluebird continues to impress with its results....

Andy,
Did you get a chance to have a direct discussion with BB on their trails and near term plans?

nanuaru73:
In this dark night you have shown us the light of hope. god willing this becomes the reality for masses soon. my prayers are are for them. may one day imay once again become beliver from athesist. :hugfriend

Andy Battaglia:
There has been some concern raised that Bluebird only mentioned two HbE beta thal patients in their latest report. I asked Bluebird for clarification and received this reply. I would say we shouldn't worry about any results that we have not seen.


--- Quote ---bluebird bio is running two trials with beta-thalassemia major patients – 204 and 205. This weekend at EHA, bluebird presented 205 because that is the European trial and EHA is a European meeting. All the patients that have been treated in 205 were presented at EHA. We expect to update on 204, our US trial, at a US meeting.
--- End quote ---

Navigation

[0] Message Index

[#] Next page

[*] Previous page